Modifying tumor-associated macrophages An important adjunct to immunotherapy

被引:14
作者
Fridlender, Zvi G. [1 ,2 ]
Albelda, Steven M. [2 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Inst Pulm Med, Jerusalem, Israel
[2] Univ Penn, Thorac Oncol Res Lab, Philadelphia, PA 19104 USA
关键词
tumor associated macrophages; immunotherapy; lung cancer; DMXAA; vaccines; AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; LUNG-CANCER; ACTIVATION; SIGNALS; DMXAA;
D O I
10.4161/onci.26620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The therapeutic success of immunotherapy requires specific alterations of the tumor microenvironment and/or the inhibition of tumor-elicited immunosuppression. Tumor-associated macrophages (TAMs) are a major component of the tumor microenvironment. We have recently shown that modulating TAMs dramatically augments the efficacy of immunotherapy. TAM-activating agents should hence be considered as an addition to immunotherapy in future clinical trials.
引用
收藏
页数:3
相关论文
共 10 条
[1]   Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid [J].
Conlon, Joseph ;
Burdette, Dara L. ;
Sharma, Shruti ;
Bhat, Numana ;
Thompson, Mikayla ;
Jiang, Zhaozhao ;
Rathinam, Vijay A. K. ;
Monks, Brian ;
Jin, Tengchuan ;
Xiao, T. Sam ;
Vogel, Stefanie N. ;
Vance, Russell E. ;
Fitzgerald, Katherine A. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (10) :5216-5225
[2]   Molecular origins of cancer - Cancer immunology [J].
Finn, Olivera J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (25) :2704-2715
[3]   Using macrophage activation to augment immunotherapy of established tumours [J].
Fridlender, Z. G. ;
Jassar, A. ;
Mishalian, I. ;
Wang, L-C S. ;
Kapoor, V. ;
Cheng, G. ;
Sun, J. ;
Singhal, S. ;
Levy, L. ;
Albelda, S. M. .
BRITISH JOURNAL OF CANCER, 2013, 108 (06) :1288-1297
[4]   Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA [J].
Henare, K. ;
Wang, L. ;
Wang, L-C S. ;
Thomsen, L. ;
Tijono, S. ;
Chen, C-J J. ;
Winkler, S. ;
Dunbar, P. R. ;
Print, C. ;
Ching, L-M .
BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1134-1147
[5]   Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma [J].
Jassar, AS ;
Suzuki, E ;
Kapoor, V ;
Sun, J ;
Silverberg, MB ;
Cheung, LM ;
Burdick, MD ;
Strieter, RM ;
Ching, LM ;
Kaiser, LR ;
Albelda, SM .
CANCER RESEARCH, 2005, 65 (24) :11752-11761
[6]   Immunotherapy of cancer in 2012 [J].
Kirkwood, John M. ;
Butterfield, Lisa H. ;
Tarhini, Ahmad A. ;
Zarour, Hassane ;
Kalinski, Pawel ;
Ferrone, Soldano .
CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (05) :309-335
[7]   Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer [J].
Lara, Primo N., Jr. ;
Douillard, Jean-Yves ;
Nakagawa, Kazuhiko ;
von Pawel, Joachim ;
McKeage, Mark J. ;
Albert, Istvan ;
Losonczy, Gyoergy ;
Reck, Martin ;
Heo, Dae-Seog ;
Fan, Xiaolin ;
Fandi, Abderrahim ;
Scagliotti, Giorgio .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) :2965-2971
[8]   Cancer-promoting tumor-associated macrophages: New vistas and open questions [J].
Mantovani, Alberto ;
Germano, Giovanni ;
Marchesi, Federica ;
Locatelli, Marco ;
Biswas, Subhra K. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (09) :2522-2525
[9]   5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential [J].
Prantner, Daniel ;
Perkins, Darren J. ;
Lai, Wendy ;
Williams, Mark S. ;
Sharma, Shruti ;
Fitzgerald, Katherine A. ;
Vogel, Stefanie N. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (47) :39776-39788
[10]   Targeting tumour-associated macrophages [J].
Sica, Antonio ;
Rubino, Luca ;
Mancino, Alessandra ;
Larghi, Paola ;
Porta, Chiara ;
Rimoldi, Monica ;
Solinas, Graziella ;
Locati, Massimo ;
Allavena, Paola ;
Mantovani, Alberto .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (09) :1219-1229